QA: Rezolute Inc in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001509261_2015_Rezolute_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001509261, Rezolute Inc

  xvar xval
0 AssetsCurrent 6,307,559
1 IntangibleAssetsNetIncludingGoodwill 9,161
2 PropertyPlantAndEquipmentNet 337,932
3 remainder_Assets 750,000
4 LiabilitiesCurrent 964,040
5 LiabilitiesNoncurrent 33,881
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,141,716
9 ResearchAndDevelopmentExpense 34,317
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -4,554,421
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 7,404,652
1 Liabilities 997,921
2 Expenses 5,176,033
3 Revenues 0
4 StockholdersEquity 6,406,731
5 NetIncome -9,730,454
6 ComprehensiveNetIncome -9,730,454
7 BaseVar 9,066,514
8 EconomicCapitalRatiobeforeLimitedLiability 1.01
9 EconomicCapitalRatio 2.31

Edgar->Model Mapping

Feature Distribution

Change over Time